INCY

Q: What is the price of Incyte (INCY) today?

The price of Incyte (INCY) today is US$ 89,31, with a variation of 37.04% compared to the last year. The price of Incyte (INCY) started the year trading around US$ 69,07 and today it is at US$ 89,31. Follow the real-time price chart, the historical price of Incyte (INCY), and stock data from Ibovespa and international markets.

Q: When does Incyte (INCY) pay dividends?

Incyte (INCY) não distribuiu dividendos no último ano.

Q: Incyte (INCY) is it worth it?

Currently, Incyte (INCY) is priced at US$ 89,31, with a P/E of 19,51%, representing a deviation of 94,63% from its historical average P/E. In the last year, the stock showed a variation of 37.04% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 37,04%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Incyte (INCY)?

Investing in stocks of Incyte (INCY) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Incyte (INCY) yield today?

The yield of Incyte (INCY) was 5,64% in the last month, 37,04% in the last year and -1,25% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Incyte (INCY) today, the total investment would be US$ 8.931,00, based on the current price of US$ 89,31.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 12.239,04In 5 years: US$ 8.819,36In 10 years: 6.780,42It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Incyte Corporation

Price

US$ 89,31

variation (12m)

37,04%

p/l

19,51

p/vp

4,07

DIVIDEND YIELD

0,00%

price INCY

BVMF

INCY

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of INCY

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

5,64%

3 months

27,22%

1 year

37,04%

2 years

64,63%

5 years

-1,25%

10 years

-24,08%

Indicators INCY

check out the fundamentals of Incyte shares

P/E

19,51

Sector: -3,77 Industry: -3,77

P/SALES RATIO (PSR)

3,71

Sector: -3,52 Industry: -3,52

P/BV

4,07

Sector: 1,91 Industry: 1,91

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

14,96%

Sector: -64,24% Industry: -64,24%

ROE

20,88%

Sector: -69,36% Industry: -69,36%

ROIC

30,49%

Sector: -2.091,13% Industry: -2.091,13%

NET MARGIN

18,99%

Sector: -43,38% Industry: -43,38%

GROSS MARGIN

92,88%

Sector: 39,75% Industry: 39,75%

OPERATING MARGIN

21,69%

Sector: -42,61% Industry: -42,61%

P/EBITDA

12,53

Sector: -3,66 Industry: -3,66

P/EBIT

13,43

Sector: -3,95 Industry: -3,95

P/ASSET

2,92

Sector: 1,41 Industry: 1,41

BVPS

21,50

Sector: 1,83 Industry: 1,83

EPS

4,49

Sector: -2,14 Industry: -2,14

EQUITY / ASSETS

0,72

Sector: 0,41 Industry: 0,41

CAGR REVENUES 5 YEARS

11,45%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

0,00%

Sector: - Industry: -

FAIR PRICE OF Incyte ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 89,31

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-47,82%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

INCY indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	18,40	0,00	0,00%	2,65%	US$ 462,14 B	27,26%
PFE	12,73	1,54	12,08%	7,10%	US$ 136,89 B	16,84%
ABBV	107,86	-2.941,16	-2.726,81%	2,82%	US$ 405,88 B	6,45%
NVO	14,80	9,31	62,86%	3,10%	US$ 241,78 B	35,63%
MRK	12,97	4,34	33,44%	3,82%	US$ 212,82 B	25,79%
AZN	31,65	5,86	18,51%	1,85%	US$ 262,54 B	14,68%
BMY	17,35	5,01	28,87%	5,72%	US$ 87,58 B	10,58%
GILD	24,23	7,80	32,21%	2,56%	US$ 152,90 B	21,87%
ZTS	24,54	12,88	52,48%	1,34%	US$ 64,11 B	27,83%
HALO	14,55	24,37	167,47%	0,00%	US$ 8,11 B	47,28%
REGN	13,61	2,03	14,89%	0,46%	US$ 60,70 B	31,37%
AMGN	24,29	21,64	89,11%	3,14%	US$ 160,76 B	18,96%
VRTX	29,45	6,24	21,18%	0,00%	US$ 107,12 B	31,86%
MCK	31,05	-113,85	-366,63%	0,38%	US$ 98,25 B	0,84%
CAH	23,85	-14,13	-59,26%	1,30%	US$ 37,23 B	0,70%
ADMA	16,56	8,69	52,45%	0,00%	US$ 3,46 B	44,06%
BIIB	13,73	1,19	8,68%	0,00%	US$ 21,02 B	15,31%

comparison of INCY with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History INCY

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Incyte

Incyte Corporation

Average user rating I10

4.0 (2 people)

Estados Unidos

34 years

Foundation: 1991

1993

Year of debut on the stock exchange - 32 years

1.773

Employees

The Company Incyte Corporation (Estados Unidos), is listed on Nasdaq with a market value of $ 16,99 Billions, having a net worth of $ 4,17 Billions.

With a total of 1.773 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 4,59 Billions, which generated a profit in the amount of $ 870,87 Milhões.

As for its main indicators, the Company has a P/E ratio of 19,51, a P/BV ratio of 4,07 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker INCY.

Market value

US$ 16,99 Billions

Net worth

US$ 4,17 Billions

US$ 4.170.900.000,00

Assets

US$ 5,82 Billions

US$ 5.821.350.000,00

Total Number of Shares

194,00 Milhões

194.000.000

Average Daily Trading Volume

US$ 1,77 Million

US$ 1.765.577,12

Sector

Health Care

Industry

Biotechnology

INCY

INCY revenue and profits

INCY results

DRAG THE FRAME TO SEE MORE DATA

INCY cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 792,97 57,73% (12M)

P/L

31,05

0,38%

ROE

-366,63%

P/VP

-113,85

CAH - Cardinal Health

US$ 159,16 43,94% (12M)

P/L

23,85

1,30%

ROE

-59,26%

P/VP

-14,13

JNJ - Johnson & Johnson

US$ 192,47 22,22% (12M)

P/L

18,40

2,65%

ROE

0,00%

P/VP

0,00

MRK - Merck & Co.

US$ 87,18 --14,61% (12M)

P/L

12,97

3,82%

ROE

33,44%

P/VP

4,34

ABBV - AbbVie

US$ 228,25 25,55% (12M)

P/L

107,86

2,82%

ROE

-2.726,81%

P/VP

-2.941,16

PFE - Pfizer

US$ 24,67 --5,50% (12M)

P/L

12,73

7,10%

ROE

12,08%

P/VP

1,54

AZN - AstraZeneca

US$ 83,40 12,23% (12M)

P/L

31,65

1,85%

ROE

18,51%

P/VP

5,86

BFRA - Biofrontera

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-893,55%

P/VP

0,00

MCK - McKesson

US$ 792,97 57,73% (12 M)

P/L

31,05

0,38%

ROE

-366,63%

P/VP

-113,85

CAH - Cardinal Health

US$ 159,16 43,94% (12 M)

P/L

23,85

1,30%

ROE

-59,26%

P/VP

-14,13

JNJ - Johnson & Johnson

US$ 192,47 22,22% (12 M)

P/L

18,40

2,65%

ROE

0,00%

P/VP

0,00

MRK - Merck & Co.

US$ 87,18 --14,61% (12 M)

P/L

12,97

3,82%

ROE

33,44%

P/VP

4,34

ABBV - AbbVie

US$ 228,25 25,55% (12 M)

P/L

107,86

2,82%

ROE

-2.726,81%

P/VP

-2.941,16

PFE - Pfizer

US$ 24,67 --5,50% (12 M)

P/L

12,73

7,10%

ROE

12,08%

P/VP

1,54

AZN - AstraZeneca

US$ 83,40 12,23% (12 M)

P/L

31,65

1,85%

ROE

18,51%

P/VP

5,86

Frequently Asked Questions

What is the price of Incyte (INCY) today?

The price of Incyte (INCY) today is US$ 89,31, with a variation of 37.04% compared to the last year. The price of Incyte (INCY) started the year trading around US$ 69,07 and today it is at US$ 89,31. Follow the real-time price chart, the historical price of Incyte (INCY), and stock data from Ibovespa and international markets.

When does Incyte (INCY) pay dividends?

Incyte (INCY) não distribuiu dividendos no último ano.

Incyte (INCY) is it worth it?

Currently, Incyte (INCY) is priced at US$ 89,31, with a P/E of 19,51%, representing a deviation of 94,63% from its historical average P/E. In the last year, the stock showed a variation of 37.04% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 37,04%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Incyte (INCY)?

Investing in stocks of Incyte (INCY) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Incyte (INCY) yield today?

The yield of Incyte (INCY) was 5,64% in the last month, 37,04% in the last year and -1,25% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of Incyte (INCY) today, the total investment would be US$ 8.931,00, based on the current price of US$ 89,31.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 12.239,04
In 5 years: US$ 8.819,36
In 10 years: 6.780,42

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

INCY

Incyte Corporation

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of INCY

check out the fundamentals of Incyte shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Incyte

Incyte Corporation

Estados Unidos

34 years

1993

1.773

PROFIT X PRICE INCY

INCY results

INCY cash flow

evolution of assets - INCY

INCY balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions